8-K
Current Report
PharmaCyte Biotech, Inc. Filed Acc 0001019687-14-002185
Material agreement · Agreement ended
- Item 1.01 Entry into a material definitive agreement
- Item 1.02 Termination of a material definitive agreement
From the SEC's structured data for this filing
Loading nuvilex_8k.htm…